Marianne Grønlie Guren
机构: MD PhD, Oslo University Hospital
每年引用次数
引用次数
引用: 7,461
H-指数: 42
I10-指数 : 81
出版物: 182
Measuring What Matters To Adolescents And Young Adults With Cancer: The Importance Of Capturing Positive Experiences
Samantha Sodergren , Olga Husson , Gudrun Rohde , Ali Alkan
Pediatric Blood & Cancer 70 ( S8) S15 -S16
2023
" Sometimes We Think About It But Don't Talk About It" Asking Adolescents And Young Adults With Cancer To Evaluate Sensitive Areas Of Life
Samantha Sodergren , Olga Husson , Gudrun Rohde , Ali Alkan
Pediatric Blood & Cancer 70 ( S8) S17 -S17
2023
Distinctions between self-report and performance-based measures of physical function in older patients prior to chemotherapy
Ann Helen Torstveit , Borghild Løyland , Ellen Karine Grov , Marianne Guren
Cancer Nursing 44 ( 6) E735 -E744
9
2021
International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): Defining the outcomes from the CORMAC core outcome set
Robert Samuel , David Sebag-Montefiore , Richard Adams , Maria Hawkins
2022
2581: PET/MR imaging biomarkers of radioresistance in anal cancer patients
Tiril Hillestad , Ragnhild Wisted , Eirik Malinen , Marianne Guren
Radiotherapy and Oncology 194 S1547 -S1548
2024
One-year conditional survival in surgically treated older colorectal cancer patients: a EURECCA European comparison
Renu Bahadoer , Esther Bastiaannnet , Amanda Bos , Elizabeth van Eycken
European Journal of Surgical Oncology 46 ( 2) e27 -e27
2020
SO-35 Tumor infiltrating CD3 lymphocytes and CD68 macrophages are associated with long-time survival in metastatic colorectal cancer patients treated with chemotherapy
K. Aasebø , J. Bruun , C. Bergsland , G. Eide
Annals of Oncology 31 ( 53)
2020
6539 POSTER Radiotherapy of Anal Carcinoma – Outcome in an Unselected National Cohort
A. Bentzen , M. Guren , E. Wanderás , O. Dahl
European Journal of Cancer 47
2011
Two countries - two treatment strategies for rectal cancer
M. Guren , T.A. Myklebust , K. Lundqvist , A. Wibe
European Journal of Cancer 72
2017
PO-0719: Target delineation of anal cancer based on MR or PET - an inter-observer, inter-modality study
E. Rusten , B.L. Rekstad , C. Undseth , G. Al-Haidari
Radiotherapy and Oncology 119
2016
PO-0779: Multicenter study of palliative pelvic radiation for symptomatic primary and recurrent rectal cancer
M. Cameron , C. Kersten , I. Vistad , R. Van Helvoirt
Radiotherapy and Oncology 119
1
2016
1057 poster LATE FUNCTIONAL OUTCOME AND QUALITY OF LIFE AFTER RADIOTHERAPY AND SURGERY FOR RECTAL CANCER
M. Guren , K. Bruheim , B.L. Rekstad , K.M. Tveit
Radiotherapy and Oncology 99
2011
OC-0054: A prospective multicenter study of palliative pelvic radiotherapyfor symptomatic incurable prostate cancer
M. Cameron , C. Kersten , I. Vistad , R. Van Helvoirt
Radiotherapy and Oncology 115
2015
2267 Rising incidence and improved survival of squamous cell carcinoma of the anal canal in Norway 1980–2011
M. Guren , B. Aagnes , M. Nygåard , O. Dahl
European Journal of Cancer 51
2015
InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naïve disease - An International Rare Cancers Initiative (IRCI) trial
S. Rao , F. Sclafani , C. Eng , M. Grønlie Guren
Annals of Oncology 29
14
2018
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Renu R Bahadoer , Esmée A Dijkstra , Boudewijn van Etten , Corrie A M Marijnen
Lancet Oncology 22 ( 1) 29 -42
530
2021
Total Mesorectal Excision Technique-Past, Present, and Future
Joep Knol , Deborah S Keller ,
Clinics in Colon and Rectal Surgery 33 ( 03) 134 -143
35
2020
Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC)? Protocol for the international, multicentre, rolling phase II/III partially randomized patient preference trial evaluating long-course concurrent chemoradiotherapy versus short-course radiotherapy organ preservation approaches
Simon P Bach , STAR‐TREC Collaborative ,
Colorectal Disease 24 ( 5) 639 -651
16
2022
Interventional Cryoneurolysis: What Is the Same, What Is Different, What Is New?
Ross W Bittman , Keywan Behbahani , Felix Gonzalez , J David Prologo
Seminars in Interventional Radiology 36 ( 5) 374 -380
6
2019
Microsatellite instability in young patients with rectal cancer: molecular findings and treatment response
REACCT Collaborative , Alexandra M Zaborowski , Ahmed Abdile , Michel Adamina
British Journal of Surgery 109 ( 3) 251 -255
13
2022